EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Nifuroxazide protects against diabetic neuropathy in rats by enhancing Nrf2/HO-1 signaling and inhibiting the NF-κB and JAK-1/STAT3 pathways

Omar Babateen

Annals of Clinical and Analytical Medicine · 2026-11-01 · 17 (11) · 1156-1161

DOI: 10.4328/acam.23051 ↗
AbstractBibliografische Angaben

Abstract

Aim Diabetic neuropathy remains one of the most debilitating complications of diabetes, driven by oxidative stress, chronic inflammation, and neuronal apoptosis. This work explored the protective role of nifuroxazide (NIF), a known signal transducer and activator of transcription 3 (STAT3) inhibitor, in a rat model of streptozotocin-induced peripheral neuropathy. Methods Forty male albino rats were divided into four groups: healthy controls, NIF-treated controls, diabetic controls, and diabetic rats receiving NIF. After induction of diabetes and stabilization, NIF was administered orally for four weeks. Results Biochemical evaluation revealed that diabetes markedly increased lipid peroxidation and reduced antioxidant enzyme activity, while NIF treatment restored superoxide dismutase and catalase activities and lowered malondialdehyde levels. These antioxidant effects were accompanied by activation of the nuclear factor erythroid 2–related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway. Inflammatory analysis showed that diabetes elevated phosphorylated Janus kinase 2 (JAK2)/STAT3, nuclear factor kappa B (NF-κB), and pro-inflammatory cytokines, whereas NIF significantly suppressed these mediators. Apoptotic markers, including caspase-3 and B-cell lymphoma 2 (Bcl-2)–associated X protein (Bax), were upregulated in diabetic nerves, with a parallel decline in Bcl-2; NIF reversed these changes, indicating anti-apoptotic efficacy. Histological examination further confirmed that NIF preserved sciatic nerve architecture, reducing vacuolation, demyelination, and endoneurial disruption. Conclusion Overall, NIF demonstrated a multifaceted neuroprotective effect by attenuating oxidative stress, dampening inflammatory signaling, and preventing apoptosis. These findings suggest that NIF may represent a promising therapeutic candidate for diabetic neuropathy, acting through coordinated modulation of antioxidant, inflammatory, and apoptotic pathways.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →